Special notice: Important policy changes

May 2025Important Notices

Effective June 1, 2025, UPMC Health Plan will be implementing policy changes that will require providers to obtain prior authorizations for services listed in the following policies. For more information, please visit upmchp.us/policiesandprocedures.

  • Varicose Veins – MP.066 is being retired and will be replaced by Varicose Veins – MP.PA.145.
  • Genetic Testing – Hereditary and Multifactorial Diseases – MP.PA.118 is a new prior authorization policy.

     

  • Laparoscopic Cholecystectomy, 18 Years Old and Older – MP.PA.146 is a new prior authorization policy.

     

  • Diagnostic and Surveillance Colonoscopy, 18 Years Old and Older – MP.PA.147 is a new prior authorization policy.

     

  • Cardiac Ablation Procedures, 18 Years Old and Older – MP.PA.148 is a new prior authorization policy.

Again, prior authorizations will be implemented in accordance with these policies beginning June 1.

If you have any questions or concerns about these policy changes, please contact your physician account executive or call Provider Services at 1-866-918-1595.

Thank you for the excellent care and support you provide to our members.


Recent Announcements

Clinical workflow changes through Epic®

Changes are coming for network providers that utilize Provider OnLine to submit specific information to UPMC Health Plan. Select activities that were previously completed in Provider OnLine will now transition to UPMC Health Plan Tapestry Link.
Sep. 2026Important Notices

CME Webinar: Lifestyle Medicine in Practice: Evidence‑Based Strategies for Chronic Disease Care

Please join us for a live, CME-accredited webinar on Wednesday, Sept. 23 from noon to 1 p.m., that will provide an overview on lifestyle medicine. Participants will learn how to integrate six core domains—nutrition, physical activity, sleep, stress management, avoidance of risky substances, and social connection—into routine care using practical tools such as brief counseling, motivational interviewing, and team-based strategies.
Sep. 2026Education/Webinars

Voluntary nationwide recall: Thyroid (Vitruvias – August 2026)

Vitruvias Therapeutics Inc. is recalling one lot, lot 504950, of Thyroid Tablets, USP 30 mg. Thyroid Tablet is used to treat hypothyroidism (underactive thyroid).
Sep. 2026Pharmacy Updates